Cordyceps occupies an odd space in modern supplementation: a traditional Chinese tonic with genuine pharmacological interest but a clinical evidence base that doesn't match the marketing hype. The key distinction most consumers miss is that virtually no supplement contains wild Ophiocordyceps sinensis — it's ecologically threatened and costs more per gram than gold. What you're buying is either a fermented mycelial extract (Cs-4) or cultivated Cordyceps militaris. Both are valid; neither is the legendary Himalayan fungus.
The Chen 2010 trial is the most-cited positive study: 20 healthy elderly adults (ages 50–75) took 333 mg Cs-4 three times daily for 12 weeks. Metabolic threshold improved 10.5% and ventilatory threshold 8.5% — meaningful for older adults wanting to maintain exercise capacity. But VO2max didn't budge, and the trial was small.
The problem is the athlete trials. Parcell 2004 gave 22 male cyclists 3 g/day Cs-4 for 5 weeks and found nothing. Earnest 2004 tested a commercial herbal formula with cordyceps in cyclists — nothing. Colson 2005 tested cordyceps plus rhodiola in cyclists — nothing on muscle oxygen saturation or performance. The pattern is consistent: if you're already trained, cordyceps doesn't add much.
The immune and anti-fatigue claims have even less RCT support. A few small studies show increased NK cell activity and reduced oxidative stress markers, but the trial quality is low and sample sizes are tiny. The Klupp 2015 Cochrane review on reishi for cancer is sometimes cited in cordyceps marketing by association — that's a different mushroom.
Practical guidance: 1000–3000 mg/day of a Cs-4 or militaris extract from a reputable source (Real Mushrooms, Host Defense, Nootropics Depot). Expect modest benefits if you're older or untrained; don't expect ergogenic magic if you're already fit. The traditional tonic framing — gentle support, not dramatic intervention — is closer to the evidence than the supplement industry's performance claims.
Keystone references: Chen et al. 2010 (J Altern Complement Med, PMID 20804368 — elderly exercise trial); Parcell et al. 2004 (Int J Sport Nutr Exerc Metab, PMID 15118196 — null cyclist trial); Colson et al. 2005 (J Strength Cond Res, PMID 15903375 — null cyclist trial with rhodiola).